IH Interests: Stroke

IN THE NEWS

Route 92 Medical Announces $50 Million Series F Extension Equity Financing

IN THE NEWS

Route 92 Medical Gains EU and MDSAP Certification for its Neurovascular Stroke-Intervention-Focused Product Portfolio

FDA, IN THE NEWS

Route 92 Medical Announces Results of SUMMIT MAX Clinical Trial Showing Highest First Pass Effect Ever Reported in a Randomized Endovascular Stroke Thrombectomy Study